Benzinga | May 13, 2021 06:25AM EDT

HC Wainwright & Co. Maintains Buy on Verastem, Raises Price Target to $4

HC Wainwright & Co. analyst Sean Lee maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $3 to $4.